CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
Buprenorphinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00023283
NCT00023283Phase 2Completed
CompareCT.gov

Counseling Conditions for Thrice Weekly Buprenorphine in a Primary Care Clinic

Yale University·interventional·Posted Aug 31, 2001·Updated Jun 29, 2020

In Brief

A Phase 2 clinical trial evaluating Buprenorphine for Heroin Dependence and 2 related conditions. Completed, across 1 site.

Detailed Summary

The purpose of this study is to compare the Standard Medical Management (SMM) vs. SMM enhanced with additional education about addiction and recovery (Enhanced Medical Management, EMM)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeroin Dependence, Opioid-Related Disorders, Substance Abuse, Intravenous
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 2CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 31, 2001
Enrollment StartAug 1, 2000
Primary CompletionDec 1, 2003
Study CompletionFeb 1, 2004
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 24.8 years ago

Interventions

Buprenorphinedrug

1. Experimental Standard Medical Management with once-weekly medication dispensing 2. Experimental Standard Medical Management with thrice-weekly medication dispensing 3. Experimental Enhanced Medical Management with thrice-weekly medication dispensing